215 related articles for article (PubMed ID: 32929501)
1. Utilization and procedural adverse outcomes associated with Watchman device implantation.
Khalil F; Arora S; Killu AM; Tripathi B; DeSimone CV; Egbe A; Noseworthy PA; Kapa S; Mulpuru S; Gersh B; Mohamad A; Friedman P; Holmes D; Deshmukh AJ
Europace; 2021 Feb; 23(2):247-253. PubMed ID: 32929501
[TBL] [Abstract][Full Text] [Related]
2. National Yearly Trend of Utilization and Procedural Complication of the Watchman Device in the United States.
Shrestha B; Poudel B; Poudel D; Diaz Fraga J
Cureus; 2022 Jun; 14(6):e25567. PubMed ID: 35784996
[TBL] [Abstract][Full Text] [Related]
3. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices.
Price MJ; Friedman DJ; Du C; Wang Y; Lin Z; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 Nov; 15(21):2115-2123. PubMed ID: 36357014
[TBL] [Abstract][Full Text] [Related]
4. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in-hospital outcomes and complications of left atrial appendage closure with the Watchman device between males and females.
Alhuarrat MAD; Pargaonkar S; Rahgozar K; Safiriyu I; Zhang X; Faillace RT; Di Biase L
Europace; 2023 Aug; 25(9):. PubMed ID: 37503957
[TBL] [Abstract][Full Text] [Related]
6. The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTION.
Paitazoglou C; Meincke F; Bergmann MW; Eitel I; Fink T; Vireca E; Wohlmuth P; Veliqi E; Willems S; Markiewicz A; Grygier M
Heart Rhythm; 2022 Jun; 19(6):917-926. PubMed ID: 35181483
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry.
Mazzone P; D'Angelo G; Regazzoli D; Molon G; Senatore G; Saccà S; Canali G; Amellone C; Turri R; Bella PD
J Interv Card Electrophysiol; 2018 Jun; 52(1):47-52. PubMed ID: 29525913
[TBL] [Abstract][Full Text] [Related]
8. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
9. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
[TBL] [Abstract][Full Text] [Related]
10. Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device.
Cruz-González I; Korsholm K; Trejo-Velasco B; Thambo JB; Mazzone P; Rioufol G; Grygier M; Möbius-Winkler S; Betts T; Meincke F; Sandri M; Schmidt B; Schmitz T; Nielsen-Kudsk JE
JACC Cardiovasc Interv; 2020 Dec; 13(23):2732-2741. PubMed ID: 33189641
[TBL] [Abstract][Full Text] [Related]
11. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.
Boersma LV; Schmidt B; Betts TR; Sievert H; Tamburino C; Teiger E; Pokushalov E; Kische S; Schmitz T; Stein KM; Bergmann MW;
Eur Heart J; 2016 Aug; 37(31):2465-74. PubMed ID: 26822918
[TBL] [Abstract][Full Text] [Related]
12. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and safety of left atrial appendage occlusion guided by procedural fluoroscopy only: A pilot study.
Wang J; Rong B; Zhang K; Chen T; Lin M; Han W; Sha R; Wang S; Feng X; Zhong JQ
Pacing Clin Electrophysiol; 2021 Jul; 44(7):1207-1215. PubMed ID: 34101856
[TBL] [Abstract][Full Text] [Related]
14. MAUDE Database Analysis of Post-Approval Outcomes following Left Atrial Appendage Closure with the Watchman Device.
Ledesma PA; Uzomah UA; Yu X; Shaqdan A; Khaloo P; Galvin J; Mansour M; Ptaszek LM; Ruskin JN
Am J Cardiol; 2021 Aug; 152():78-87. PubMed ID: 34116792
[TBL] [Abstract][Full Text] [Related]
15. Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry.
Daimee UA; Wang Y; Masoudi FA; Varosy PD; Friedman DJ; Du C; Koutras C; Reddy VY; Saw J; Price MJ; Kusumoto FM; Curtis JP; Freeman JV
Circ Cardiovasc Qual Outcomes; 2022 Aug; 15(8):e008418. PubMed ID: 35959677
[TBL] [Abstract][Full Text] [Related]
16. Association of Hospital Procedural Volume With Outcomes of Percutaneous Left Atrial Appendage Occlusion.
Nazir S; Ahuja KR; Kolte D; Isogai T; Michihata N; Saad AM; Ramanathan PK; Krishnaswamy A; Wazni OM; Saliba WI; Gupta R; Kapadia SR
JACC Cardiovasc Interv; 2021 Mar; 14(5):554-561. PubMed ID: 33663783
[TBL] [Abstract][Full Text] [Related]
17. Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry.
Berti S; De Caterina AR; Grasso C; Casu G; Giacchi G; Pagnotta P; Maremmani M; Mazzone P; Limite L; Tomassini F; Greco F; Romeo MR; Caramanno G; Fassini G; Geraci S; Chiarito M; Tondo C; Tamburino C; Contarini M
Front Cardiovasc Med; 2023; 10():1115811. PubMed ID: 37180775
[TBL] [Abstract][Full Text] [Related]
18. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
Turagam MK; Lavu M; Afzal MR; Vuddanda V; Jazayeri MA; Parikh V; Atkins D; Bommana S; DI Biase L; Horton R; Bai R; Swarup V; Cheng J; Natale A; Lakkireddy D
J Cardiovasc Electrophysiol; 2017 Feb; 28(2):139-146. PubMed ID: 27943538
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk.
Messele LF; Khan MZ; Darden D; Agarwal S; Krishan S; Pasupula DK; Ul Abideen Asad Z; Balla S; Singh GD; Srivatsa UN; Munir MB
Europace; 2023 Apr; 25(4):1415-1422. PubMed ID: 36881781
[TBL] [Abstract][Full Text] [Related]
20. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.
Phillips KP; Pokushalov E; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
Europace; 2018 Jun; 20(6):949-955. PubMed ID: 29106523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
